Research Library
PRECLINICAL

GHRP-6

Also known as: GHRP-6, Growth hormone releasing peptide 6

Endocrine SignalingReceptor Pharmacology
ClassificationGrowth-hormone-releasing peptide / GH secretagogue.
Catalog / SKUGHRP-6 · MX-GHRP6-010 · 10 mg
TargetsGrowth-hormone secretagogue receptor (ghrelin receptor, GHS-R)

Molecular Overview

GHRP-6 is a growth-hormone-releasing peptide studied for its action at the growth-hormone secretagogue (ghrelin) receptor in endocrine research.

Mechanistic Background

Agonism at GHS-R stimulates GH-release pathways in experimental models.

What Researchers Study

Research has examined ghrelin-receptor pharmacology and GH-release endpoints.

Evidence Landscape

Current evidence level: PRECLINICAL. Preclinical evidence does not equate to demonstrated human efficacy.

Research Limitations

Largely preclinical characterization.

Research Use Only

Molecularix Biolabs provides research materials for legitimate laboratory research. Information in this Research Library is provided for educational and scientific reference purposes and is not medical advice, treatment guidance, or a recommendation for human or veterinary use.